Abstract:Activation of fetal membrane TLR4 by Gram‐negative bacterial LPS leads to a chemokine IL‐8 and uric acid‐driven NLRP3 inflammasome‐mediated IL‐1ß response. Downstream of TLR4 activation by LPS, TLR8‐activating miR‐146a‐3p acts as an intermediate danger signal to drive these fetal membrane inflammasome‐dependent and inflammasome‐independent mechanisms of inflammation. Preterm birth is the largest contributor to neonatal morbidity and is often associated with chorioamnionitis, defined as inflammation/infection of the fetal membranes (FMs). Chorioamnionitis is characterised by neutrophil infiltration of the FMs and is associated with elevated levels of the neutrophil chemoattractant, interleukin (IL)‐8 and the proinflammatory cytokine, IL‐1β. While FMs can respond to infections through innate immune sensors, such as toll‐like receptors (TLRs), the downstream mechanisms by which chorioamnionitis arises are not fully understood. A novel group of non‐classical microRNAs (miR‐21a, miR‐29a, miR‐146a‐3p, Let‐7b) function as endogenous danger signals by activating the ssRNA viral sensors TLR7 and TLR8. In this study, the pro‐inflammatory roles of TLR7/TLR8‐activating miRs were examined as mediators of FM inflammation in response to bacterial lipopolysaccharide (LPS) using an in vitro human FM explant system, an in vivo mouse model of pregnancy, and human clinical samples. Following LPS exposure, miR‐146a‐3p was significantly increased in both human FM explants and wild‐type mouse FMs. Expression of miR‐146a‐3p was also significantly elevated in FMs from women with preterm birth and chorioamnionitis. FM IL‐8 and inflammasome‐mediated IL‐1β production in response to LPS was dependent on miR‐146a‐3p and TLR8 downstream of TLR4 activation. In wild‐type mice, LPS exposure increased FM IL‐8 and IL‐1β production and induced preterm birth. In TLR7−/−/TLR8−/− mice, LPS exposure was able to initiate but not sustain preterm birth, and FM inflammation was reduced. Together, we demonstrate a novel signalling mechanism at the maternal‐fetal interface in which TLR8‐activating miR‐146a‐3p acts as an intermediate danger signal to drive FM inflammasome‐dependent and ‐independent mechanisms of inflammation and, thus, may play a role in chorioamnionitis and subsequent preterm birth.

Easy Going Vector Graphics as Textures on the GPU

Fetal and maternal NLRP3 signaling is required for preterm labor and birth

Intra-amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome†

A key role for NLRP3 signaling in preterm labor and birth driven by the alarmin S100B

A Factor Model for the Calculation of Portfolio Credit VaR

The Local and Systemic Immune Response to Intrauterine LPS in the Prepartum Mouse

On the Weight Enumeration of Weights Less than 2.5d of Reed-Muller Codes

Nlrp3 Inflammasome Activation Of Mast Cells By Estrogen Via The Nuclear-Initiated Signaling Pathway Contributes To The Development Of Endometriosis

IL-27 Mediates Pro-Inflammatory Effects via the ERK Signaling Pathway During Preterm Labor

Interaction between NF-κB and AP-1 and their intracellular localization at labor in human late pregnant myometrial cells in vivo and in vitro

Hydrogen Sulfide Contributes to Uterine Quiescence Through Inhibition of NLRP3 Inflammasome Activation by Suppressing the TLR4/NF-κB Signalling Pathway

TLR8‐activating miR‐146a‐3p is an intermediate signal contributing to fetal membrane inflammation in response to bacterial LPS

A pivotal role for the IL-1β and the inflammasome in preterm labor

NLRP3 Inflammasome and Its Critical Role in Gynecological Disorders and Obstetrical Complications

Integration of transcriptomics and metabolomics reveals the responses of the maternal circulation and maternal-fetal interface to LPS-induced preterm birth in mice

Role of the NLRP3 Inflammasome in Preeclampsia

[Infections after osteosyntheses].

Prospective assessment of the role of antibiotic prophylaxis in ERCP.

Role of the NLRP3 inflammasome in gynecological disease

Long-term risk in subjects with white-coat hypertension.

IL-1 and TNF mediates IL-6 signaling at the maternal-fetal interface during intrauterine inflammation